CVRX

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About CVRx Inc

CEO
Employees
63
Headquarters

News

CVRx, Inc. (CVRX) Q4 2023 Earnings Call Transcript
Jan 26, 2024 03:37am

No summary available.


Source:Seeking Alpha
CVRx Inc (CVRX) Reports Substantial Revenue Growth in —…—‘
Jan 25, 2024 21:39pm

CVRx Inc (CVRX) Reports Substantial Revenue Growth in 2023


Source:GuruFocus
CVRx: Q4 Earnings Insights
Jan 25, 2024 21:10pm

CVRx (NASDAQ: CVRX ) reported its Q4 earnings results on Thursday, January 25, 2024 at 04:15 PM. Here''s what investors need to know about the announcement. Earnings CVRx beat estimated earnings by 18.52%, reporting an EPS of $-0.44 versus an … Full story available on Benzinga.com


Source:Benzinga
CVRx GAAP EPS of -$0.44 beats by $0.11, revenue of $11.3M beats by $0.23M
Jan 25, 2024 21:08pm

No summary available.


Source:Seeking Alpha
Earnings Outlook For CVRx
Jan 24, 2024 20:01pm

CVRx (NASDAQ: CVRX ) is set to give its latest quarterly earnings report on Thursday, 2024-01-25. Here''s what investors need to know before the announcement. Analysts estimate that CVRx will report an earnings per share (EPS) of $-0.55. CVRx bulls will hope to hear the company announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next … Full story available on Benzinga.com


Source:Benzinga
CVRx announces CEO retirement, reports Q4 & FY prelim results
Jan 08, 2024 18:20pm

CVRx, Inc announces CEO retirement and strong financial results, with projected revenue growth for 2023 and 2024 exceeding estimates.


Source:Seeking Alpha
CVRx: Recent Good News Seems Fully Priced In Now
Dec 28, 2023 18:41pm

Discover if CVRx, Inc. can sustain its recent surge in stock prices and overcome potential profit taking in 2024. Click here to read more about the stock.


Source:Seeking Alpha
CVRx to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 27, 2023 21:30pm

MINNEAPOLIS, Dec. 27, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that the management team will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024. The Company is scheduled to present at 3:45pm Pacific Time the same day via webcast.


Source:GlobeNewswire